Gary Mason
Overview
Explore the profile of Gary Mason including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
1181
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Azuma K, Mason G, Monnet E
Am J Vet Res
. 2024 Jul;
85(9).
PMID: 38991542
Objective: To assess the thickness of each layer of the gallbladder wall with different diseases in dogs. Sample: 72 gallbladders. Methods: Retrospective study of dogs that underwent cholecystectomy. Histopathological specimens...
2.
Agerholm J, Mason G, Steffen D
J Vet Diagn Invest
. 2024 Apr;
36(4):583-585.
PMID: 38616510
Distinct solitary dermal nodules, either covered by an alopecic, or sometimes ulcerated, epidermis, were noticed on the head of a stillborn Holstein calf. The head was submitted for autopsy, and...
3.
Das A, Sudhaman S, Morgenstern D, Coblentz A, Chung J, Stone S, et al.
Nat Med
. 2022 Jan;
28(1):125-135.
PMID: 34992263
Cancers arising from germline DNA mismatch repair deficiency or polymerase proofreading deficiency (MMRD and PPD) in children harbour the highest mutational and microsatellite insertion-deletion (MS-indel) burden in humans. MMRD and...
4.
Durno C, Ercan A, Bianchi V, Edwards M, Aronson M, Galati M, et al.
J Clin Oncol
. 2021 May;
39(25):2779-2790.
PMID: 33945292
Purpose: Constitutional mismatch repair deficiency syndrome (CMMRD) is a lethal cancer predisposition syndrome characterized by early-onset synchronous and metachronous multiorgan tumors. We designed a surveillance protocol for early tumor detection...
5.
Campbell B, Galati M, Stone S, Riemenschneider A, Edwards M, Sudhaman S, et al.
Cancer Discov
. 2021 Feb;
11(6):1454-1467.
PMID: 33563663
The RAS/MAPK pathway is an emerging targeted pathway across a spectrum of both adult and pediatric cancers. Typically, this is associated with a single, well-characterized point mutation in an oncogene....
6.
Chung J, Maruvka Y, Sudhaman S, Kelly J, Haradhvala N, Bianchi V, et al.
Cancer Discov
. 2020 Dec;
11(5):1176-1191.
PMID: 33355208
Although replication repair deficiency, either by mismatch repair deficiency (MMRD) and/or loss of DNA polymerase proofreading, can cause hypermutation in cancer, microsatellite instability (MSI) is considered a hallmark of MMRD...
7.
Dodgshun A, Fukuoka K, Edwards M, Bianchi V, Das A, Sexton-Oates A, et al.
Acta Neuropathol
. 2020 Sep;
140(5):765-776.
PMID: 32895736
Replication repair deficiency (RRD) leading to hypermutation is an important driving mechanism of high-grade glioma (HGG) occurring predominantly in the context of germline mutations in RRD-associated genes. Although HGG presents...
8.
Shuen A, Lanni S, Panigrahi G, Edwards M, Yu L, Campbell B, et al.
J Clin Oncol
. 2019 Jan;
37(6):461-470.
PMID: 30608896
Purpose: Constitutional mismatch repair deficiency (CMMRD) is a highly penetrant cancer predisposition syndrome caused by biallelic mutations in mismatch repair (MMR) genes. As several cancer syndromes are clinically similar, accurate...
9.
Campbell B, Light N, Fabrizio D, Zatzman M, Fuligni F, De Borja R, et al.
Cell
. 2017 Oct;
171(5):1042-1056.e10.
PMID: 29056344
We present an extensive assessment of mutation burden through sequencing analysis of >81,000 tumors from pediatric and adult patients, including tumors with hypermutation caused by chemotherapy, carcinogens, or germline alterations....
10.
Furtado A, Ceschin R, Bluml S, Mason G, Jakacki R, Okada H, et al.
Neuroimaging Clin N Am
. 2016 Nov;
27(1):155-166.
PMID: 27889021
The potential benefits of peptide-based immunotherapy for pediatric brain tumors are under investigation. Treatment-related heterogeneity has resulted in radiographic challenges, including pseudoprogression. Conventional MR imaging has limitations in assessment of...